Anika Therapeutics Inc. P/E ratio

P/E ratio of ANIK for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/E ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its earnings per share. A low P/E ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/E ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current P/E ratio of Anika Therapeutics Inc. is 123.55 (as of December 31, 2021)
  • P/E ratio for the quarter ending June 30, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly P/E ratio decreased by NaN%
  • Annual P/E ratio for 2021 was 123.55 (a Infinity% increase from previous year)
  • Annual P/E ratio for 2020 was 0.0 (a -100.0% decrease from previous year)
  • Annual P/E ratio for 2019 was 26.87 (a 3.91% increase from previous year)
Visit stockrow.com/ANIK for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/E ratio of Anika Therapeutics Inc.

Most recent P/E ratioof ANIK including historical data for past 10 years.

Interactive Chart of P/E ratio of Anika Therapeutics Inc.

Anika Therapeutics Inc. P/E ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0 0.0
2021 123.55 0.0 0.0 0.0 123.55
2020 0.0 0.0 59.89 15.63 0.0
2019 26.87 25.06 19.55 14.62 26.87
2018 25.85 31.91 26.38 36.02 25.85
2017 25.19 26.85 21.18 20.3 25.19
2016 22.57 19.94 22.83 19.61 22.57
2015 18.52 17.21 19.32 22.62 18.52
2014 15.55 14.32 18.53 17.79 15.55
2013 25.44 17.57 15.46 15.2 25.44
2012 11.3 19.58 16.9 17.01 11.3
2011 14.11 9.89 14.11

Business Profile of Anika Therapeutics Inc.

Sector: Healthcare
Industry: Medical Devices